Delcath Systems, Inc. last reported quarterly results on Aug 6, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $29.1 million (+20.6% year over year) and diluted EPS of $0.07. It usually reports 12–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Oct 19, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Monday. Based on last year's release for the same quarter on Oct 20, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 12–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 6, 2026
37 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
29
+20.6%
|
3
-1.1%
|
0.07
+0.0%
|
|
May 7, 2026
37 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
25
+26.3%
|
-1
-200.1%
|
-0.03
-200.0%
|
|
Jan 12, 2026
12 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
21
+37.3%
|
-2
+44.2%
|
-0.05
+55.2%
|
|
Oct 20, 2025
20 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
21
+83.6%
|
1
-55.5%
|
0.02
-66.7%
|
|
Aug 6, 2025
37 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
24
+211.0%
|
3
+119.6%
|
0.07
+114.6%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
20
+530.3%
|
1
+109.6%
|
0.03
+106.7%
|
|
Jan 13, 2025
13 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
15
+2701.5%
|
-3
+69.5%
|
-0.11
+78.2%
|
|
Oct 17, 2024
17 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
11
+2480.6%
|
2
+109.2%
|
0.06
+105.3%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DCTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Queensbury, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 872912
- Former names
- DELCATH SYSTEMS, INC. (until Oct 27, 2026); DELCATH SYSTEMS INC (until Apr 22, 2013)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.